• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨大细胞动脉炎伴发非典型感音神经性聋

A Giant Silence - An atypical association of sensorineural hearing loss with Giant Cell Arteritis.

机构信息

Concord Hospital, Sydney, New South Wales, Australia.

出版信息

Int J Rheum Dis. 2022 Oct;25(10):1203-1207. doi: 10.1111/1756-185X.14401. Epub 2022 Jul 26.

DOI:10.1111/1756-185X.14401
PMID:35880512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9796047/
Abstract

Giant cell arteritis (GCA) is a chronic vasculitic disorder predominantly affecting medium to large sized arteries, prevalent in the 50 plus age group. This case illustrates an atypical presentation of this disease in the form of bilateral sensorineural hearing loss (SNHL). Apart from the presence of constitutional and vertiginous symptoms, there were essentially no classical features of GCA. Differentials were broad including infection, malignancy and medication toxicity as well as brain, eye and ear syndromes such as Cogan's syndrome, all of which were eventually excluded. Her diagnosis was ultimately confirmed on positron emission tomography, which highlights the diagnostic importance of this modality. She was managed with corticosteroids then tocilizumab and is making a gradual recovery. Literature review demonstrates that SNHL is more prevalent than previously suggested in GCA, although this does not have widespread recognition. Mechanisms of SNHL in GCA include vascular occlusion, immunological mechanisms including cross reactivity with viral antigens and direct viral infection. SNHL does appear to improve with corticosteroids. This case emphasizes the importance of considering GCA as an important differential in SNHL.

摘要

巨细胞动脉炎(GCA)是一种主要影响中到大动脉的慢性血管炎疾病,在 50 岁以上人群中较为常见。本例以双侧感觉神经性听力损失(SNHL)的形式呈现出该疾病的非典型表现。除了存在全身症状和眩晕外,基本上没有 GCA 的典型特征。鉴别诊断包括感染、恶性肿瘤和药物毒性以及脑、眼和耳部综合征,如 Cogan 综合征,最终都被排除了。她的诊断最终通过正电子发射断层扫描得到确认,这凸显了该诊断方法的重要性。她接受了皮质类固醇治疗,然后是托珠单抗治疗,目前正在逐渐康复。文献回顾表明,SNHL 在 GCA 中的发病率比以前认为的要高,尽管这并没有得到广泛认可。GCA 中 SNHL 的发生机制包括血管闭塞、免疫机制,包括与病毒抗原的交叉反应和直接病毒感染。SNHL 似乎确实可以通过皮质类固醇改善。本例强调了在 SNHL 中考虑 GCA 作为重要鉴别诊断的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/9796047/51c547ecb71a/APL-25-1203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/9796047/51c547ecb71a/APL-25-1203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/9796047/51c547ecb71a/APL-25-1203-g001.jpg

相似文献

1
A Giant Silence - An atypical association of sensorineural hearing loss with Giant Cell Arteritis.巨大细胞动脉炎伴发非典型感音神经性聋
Int J Rheum Dis. 2022 Oct;25(10):1203-1207. doi: 10.1111/1756-185X.14401. Epub 2022 Jul 26.
2
Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab.早期使用托珠单抗成功治疗模仿巨细胞动脉炎的非典型科根综合征
Intern Med. 2022 Apr 15;61(8):1265-1270. doi: 10.2169/internalmedicine.7674-21. Epub 2021 Oct 5.
3
[Hearing loss in giant cell arteritis: A case report].
Rev Med Interne. 2023 Jan;44(1):31-34. doi: 10.1016/j.revmed.2022.05.008. Epub 2022 Jun 22.
4
Giant Cell Arteritis (GCA): Pathogenesis, Clinical Aspects and Treatment Approaches.巨细胞动脉炎:发病机制、临床特征及治疗方法
Curr Rheumatol Rev. 2019;15(4):259-268. doi: 10.2174/1573397115666190227194014.
5
Giant cell arteritis presenting as depressed mood and headache in an elderly patient.老年患者以情绪低落和头痛为表现的巨细胞动脉炎。
J Clin Rheumatol. 2013 Oct;19(7):405-6. doi: 10.1097/RHU.0b013e3182a701e8.
6
Update on giant cell arteritis.巨细胞动脉炎的最新进展。
Curr Opin Ophthalmol. 2003 Dec;14(6):332-8. doi: 10.1097/00055735-200312000-00003.
7
Giant Cell (Temporal) Arteritis with Persistent Bilateral Sensorineural Hearing Loss - A Likely Consequence of Delayed Institution of Glucocorticoid Therapy.巨细胞(颞)动脉炎伴持续性双侧感音神经性听力损失——糖皮质激素治疗延迟启动的可能后果
Am J Case Rep. 2017 Nov 22;18:1233-1237. doi: 10.12659/AJCR.907174.
8
[A case of temporal arteritis presenting with sensorineural hearing loss].[一例以感音神经性听力损失为表现的颞动脉炎]
Recenti Prog Med. 2001 Dec;92(12):751-3.
9
Does Tocilizumab Influence Ophthalmic Outcomes in Giant Cell Arteritis?托珠单抗是否会影响巨细胞动脉炎的眼部结局?
J Neuroophthalmol. 2022 Jun 1;42(2):173-179. doi: 10.1097/WNO.0000000000001514. Epub 2022 Apr 27.
10
Temporal arteritis and sensorineural hearing loss.
Semin Arthritis Rheum. 1998 Dec;28(3):206-9. doi: 10.1016/s0049-0172(98)80038-3.

引用本文的文献

1
Development of the inner ear and regeneration of hair cells after hearing impairment.内耳的发育及听力受损后毛细胞的再生。
Fundam Res. 2023 Nov 21;5(1):203-214. doi: 10.1016/j.fmre.2023.09.005. eCollection 2025 Jan.

本文引用的文献

1
Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines.四例与接种 SARS-CoV-2 mRNA 疫苗相关的听觉-前庭障碍。
Int J Audiol. 2023 Jun;62(6):587-591. doi: 10.1080/14992027.2022.2056721. Epub 2022 May 5.
2
Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination.评估 COVID-19 疫苗接种后的突发性感觉神经性听力损失。
JAMA Otolaryngol Head Neck Surg. 2022 Apr 1;148(4):307-315. doi: 10.1001/jamaoto.2021.4414.
3
Tinnitus, Sudden Sensorineural Hearing Loss, and Vestibular Neuritis As Complications of the Astra Zeneca COVID-19 Vaccine.
耳鸣、突发性感音神经性听力损失和前庭神经炎作为阿斯利康新冠疫苗的并发症
Cureus. 2022 Jan 3;14(1):e20906. doi: 10.7759/cureus.20906. eCollection 2022 Jan.
4
Sudden Sensorineural Hearing Loss Following the Second Dose of COVID-19 Vaccine.第二剂新冠疫苗接种后突发感音神经性听力损失
Cureus. 2021 Aug 25;13(8):e17435. doi: 10.7759/cureus.17435. eCollection 2021 Aug.
5
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.2021 年美国风湿病学会/血管炎基金会巨细胞动脉炎和 Takayasu 动脉炎管理指南。
Arthritis Care Res (Hoboken). 2021 Aug;73(8):1071-1087. doi: 10.1002/acr.24632. Epub 2021 Jul 8.
6
Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event.巨细胞动脉炎诊断时的症状性主动脉炎:主动脉事件的一个预后因素。
Arthritis Res Ther. 2021 Jan 7;23(1):14. doi: 10.1186/s13075-020-02396-5.
7
Diagnosis of giant cell arteritis.巨细胞动脉炎的诊断。
Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii5-iii16. doi: 10.1093/rheumatology/kez553.
8
Patient-reported involvement of the eighth cranial nerve in giant cell arteritis.患者报告的第八颅神经在巨细胞动脉炎中的受累情况。
Clin Rheumatol. 2019 Dec;38(12):3655-3660. doi: 10.1007/s10067-019-04747-3. Epub 2019 Aug 16.
9
Comparisons of clinical manifestations and prognosis between giant cell arteritis patients with or without sensorineural hearing loss: A retrospective study of Chinese patients.伴有或不伴有感音神经性听力损失的巨细胞动脉炎患者的临床表现及预后比较:一项针对中国患者的回顾性研究
Medicine (Baltimore). 2019 Apr;98(17):e15286. doi: 10.1097/MD.0000000000015286.
10
Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets.巨细胞动脉炎:发病机制及新的潜在治疗靶点
BMC Rheumatol. 2017 Nov 28;1:2. doi: 10.1186/s41927-017-0004-5. eCollection 2017.